This Solicitation opportunity from Department Of Defense was posted on May 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

SODIUM CHLORIDE IRR

Closed

SPE2DP-26-T-3375Federal

Submission Closed05/18/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

Federal

6505--Dutasteride CapsulesThe Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP 36E79726R0029) for the procurement of Dutasteride Capsules to serve multiple federal agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted contract aims to secure a reliable supply source for Dutasteride 0.5MG capsules in both 30-count and 90-count bottles, with annual estimated usage of approximately 3,912 and 25,502 bottles respectively. The contract will be awarded to a single responsible offeror who can provide an uninterrupted supply and will have a one-year base period followed by four one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must supply the drug under the exact name on the label, with a unique National Drug Code (NDC) exclusive to the offeror. The contractor’s label must be the sole label on the product, with VA labels designed to adhere securely on top without obscuring important information such as barcodes, expiration dates, and lot numbers. Packaging requirements include safety caps that meet specific design criteria with a minimum bottle volume of 120cc and cylindrical shape to accommodate appropriate labeling sizes. The solicitation will be released in a commercial item format in accordance with FAR Part 12 around June 22, 2026, with proposals due by July 7, 2026. Interested parties should monitor SAM.gov for updates and submit offers electronically; efforts to obtain paper copies will not be accommodated. The contract specialist and primary point of contact for this procurement is Richard Mahario.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

LEVOFLOXACIN TABLETThe contract pertains to the procurement of Levofloxacin tablets, identified by NSN/Part Number 6505-01-444-6632, with a purchase quantity of one unit under request number 7017178498. The solicitation, designated SPE2DP-26-T-3807, was issued by the Defense Logistics Agency on behalf of the Department of Defense with a posting date of June 15, 2026, and a response deadline set for June 22, 2026. This solicitation is categorized as a federal opportunity without specific set-aside conditions or NAICS code information provided. The contract will be performed within the United States, although exact location details are unspecified. The Defense Logistics Agency is managing the acquisition, and the solicitation details are accessible via a designated DIBBS URL for interested parties.

Defense Logistics Agency

POSTED

DEADLINE

Sole Source Total Parenteral Nutrition (TPN) solutions, including TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid same-day delivery, seven days a weekThis contract involves the sole source procurement of Total Parenteral Nutrition (TPN) solutions, specifically including products such as TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid. The key requirement is for same-day delivery, seven days a week, ensuring continuous availability of these critical nutritional solutions. The solicitation number is HT941026N0069, with the notice posted on June 15, 2026, and a response deadline set for June 30, 2026. The contract falls under the NAICS code 325412, associated with pharmaceutical preparation manufacturing, and is issued by the Defense Health Agency located at Camp Pendleton, California. The place of performance is identified within Washington state, ZIP code 98431, indicating where the deliveries or contract services will be conducted. There is no set-aside designation for this procurement, reflecting an open competitive strategy or a direct sole-source justification. Primary and secondary points of contact are provided for further inquiries, with the primary contact being CHA-ON Gordon. The contract aims to support the Department of Defense’s ongoing medical and nutritional needs for personnel, emphasizing timely and reliable supply chain delivery for essential TPN products.

Defense Health Agency Hcd West

POSTED

DEADLINE

Custom Sterile Compounding of Total Parenteral Nutrition (TPN) FormulationsThe contract involves the manufacture and delivery of patient-specific, sterile Total Parenteral Nutrition (TPN) formulations, including branded products such as TrophAmin®, Plenamine, Nutrilipid®, and SMOF Lipid®. These formulations must be provided in volumes ranging from 1000 to over 3000 mL, with an absolute requirement for zero tolerance for deviations, ensuring strict adherence to quality and safety standards. This precision is critical given the nature of the products and their use in patient care. Administered by the Defense Health Agency Hcd West under the Department of Defense, the contract is categorized under NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing. The contract is structured as a subcontract with a deadline for responses set for June 30, 2026. Performance is designated for an area identified by the zip code 98431. The contract underscores the importance of reliable, high-quality sterile compounding to meet defense health requirements with strict compliance to specifications and timelines.

Defense Health Agency Hcd West

POSTED

DEADLINE

Supply of Non-Substitutable Pharmaceutical IngredientsThis contract involves the supply of proprietary, branded pharmaceutical components including TrophAmin®, Plenamine, Nutrilipid®, and SMOF Lipid®, which are essential ingredients used in Total Parenteral Nutrition (TPN) formulations. The contract emphasizes full traceability and compliance with regulatory standards to ensure the safety and quality of these non-substitutable pharmaceutical ingredients. The procurement is managed by the Defense Health Agency Hcd West under the Department of Defense, reflecting the critical nature of these supplies for health services within defense operations. The solicitation was posted on June 15, 2026, with a response deadline set for June 30, 2026. The contract is classified as a subcontract under the NAICS code 325412, which pertains to pharmaceutical manufacturing. The place of performance falls within the 98431 zip code area, though specific city or state details are not disclosed. This contract supports the continued availability of specialized pharmaceutical components necessary for patient nutrition and care in military healthcare settings.

Defense Health Agency Hcd West

POSTED

2 days ago

DEADLINE

in 14 days

AI Contract Overview

This contract pertains to the procurement of Sodium Chloride Irrigation solution, specifically a 0.9% concentration in 500 mL units, intended for medical use. The item, identified by NSN 6505-01-462-4193, is to be delivered in compliance with stringent packaging and marking standards as required by the Department of Defense and DLA regulations. Packaging must ensure product protection from damage or breakage during shipping and comply with the Medical Marking Standard No. 1. The solution has a fixed shelf life of 36 months and should be stored at room temperature, avoiding excessive heat. Mercury or mercury-containing compounds are prohibited in the product and packaging unless specifically exempted for certain defense purposes. Delivery terms specify FOB destination with a 20-day delivery window, and strict inspection and acceptance at the destination point. Shipment is to be executed by the fastest traceable means, excluding parcel post, and palletization and packing must adhere to DLA’s established requirements. The contract incorporates DLA Master List technical and quality standards, with reference to applicable ASTM and military standards to ensure compliance. Communication and procurement further require adherence to federal hazardous materials packaging protocols when applicable. The contract solicitation is managed by the Medical Supply Chain Pharmacy FSA under the Department of Defense, with a response deadline of May 18, 2026, and a key point of contact for the procurement process is provided.

General Info

Procurement of 0.9% Sodium Chloride 500mL units, delivery in 20 days, strict packaging, no mercury.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

UNIT 100479 BOX 1, FPO, AP, 96675, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-3375 Medical Supply Chain

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedMay 12

Solicitation

Response DeadlineMay 18

Deadline has passed

Submission Closed

05/18/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUS

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUS

Contacts

IMERAH BURNETT

contact@example.gov

+1 (555) 000-0000

Full Description

SODIUM CHLORIDE IRR
SODIUM CHLORIDE IRRIGATION<(>,<)>
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
USP, 0.9%,500ML,18"S U/I "PACKAGE" Room temperature (25°C). Avoid excessive heat.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
MERCURY OR MERCURY CONTAINING COMPOUNDS SHALL
NOT BE INTENTIONALLY ADDED TO<(>,<)> OR COME IN DIRECT
CONTACT WITH<(>,<)> ANY HARDWARE OR SUPPLIES FURNISHED
UNDER THIS CONTRACT. EXCEPTION: FUNCTIONAL MERCURY
USED IN BATTERIES, FLUORESCENT LIGHTS, REQUIRED
INSTRUMENTS; SENSORS OR CONTROLS; WEAPON SYSTEMS;
AND CHEMICAL ANALYSIS REAGENTS SPECIFIED BY NAVSEA.
SPE2DP-26-T-3375
SECTION B
PORTABLE FLUORESCENT LAMPS AND PORTABLE INSTRUMENTS
CONTAINING MERCURY SHALL BE SHOCK PROOF AND CONTAIN
A SECOND BOUNDARY OF CONTAINMENT OF THE MERCURY OR
MERCURY COMPOUND. (IAW NAVSEA 5100-003D).
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
BAXTER HEALTHCARE CORPORATION 1G026 P/N 2F7123
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016740258 0001 PG 1.000
NSN/MATERIAL:6505014624193
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
N23199
USNS MATTHEW PERRY T-AKE 9
UNIT 100479 BOX 1
FPO AP 96675
US
SPE2DP-26-T-3375
SECTION B
PR: 7016740258 PRLI: 0001 CONT’D
RDD 777 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
N23199
USNS MATTHEW PERRY T-AKE 9
DLA VENDORS: USE VSM FOR
US
M/F: (TCN) N231996129S156
RDD: 777
PROJ: HJ5 TP 2
SUPP ADD: YSNU01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A4A DIST: 9B ADV: 2A FC: E5
Need Ship Date:00/00/0000 Original Required Delivery Date:05/14/2026
SPE2DP-26-T-3375 NSN/Part Number: 6505-01-462-4193 Quantity: 1 PG Purchase Request: 7016740258QTY: 1 Delivery: 20 days ADO